Baker Botts L.L.P., a leading international law firm, announced today that Christopher V. Ryan, Margaret J. Sampson and Stephen M. Hash have joined the firm’s Austin office as Partners.
“Chris, Margaret and Stephen are all outstanding IP lawyers with robust practices in Texas, California and across the country. Their addition to our firm will continue to grow our presence in these important markets and further highlights the focus we have placed on expanding our firm’s footprint in our 175th year,” said Andrew M. Baker, Managing Partner of Baker Botts.
“Baker Botts has one of the largest IP practices in the world. With over 150 lawyers, holding 180 advanced degrees, we are able to offer unparalleled service, experience and expertise to our high technology and life sciences clients. Chris, Margaret and Stephen all bring unique skills, which will add significant value for our clients,” said Bart Showalter, Chair of the firm’s Intellectual Property Practice.
About the Lawyers
Christopher V. Ryan is an intellectual property litigator with a background in licensing and the enforcement of patents. He has litigated a number of IP cases in the areas of semiconductors, system software, firmware and enterprise business solutions. Chris has extensive experience in both the Eastern District of Texas and the Northern District of California – two of the most active patent courts.
Margaret J. Sampson’s practice is centered on intellectual property transactions and counseling. Margaret focuses on life sciences, research tools, medical devices and pharmaceuticals. She has particular expertise in patent portfolio assessment, IP investment structuring, inbound and outbound licensing, mergers and acquisitions and joint ventures involving valuable patent assets.
Stephen M. Hash is a seasoned patent litigator. His practice focuses primarily on life sciences, pharmaceuticals and disputes under the Hatch-Waxman Act. He has acted for clients in the areas of consumer drugs, agricultural and consumer products, medical devices, research tools and diagnostics. Stephen’s specific focus is on molecular biology and immunology.
Source: www.bakerbotts.com
